Danaher (DHR) Net Cash Flow Growth (3y) (2012 - 2026)
Danaher (DHR) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 89.23% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 138.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | -43.12% |
| Mar 27, 2026 | -3.60% |
| Dec 31, 2025 | 55.09% |
| Sep 26, 2025 | -46.30% |
| Jun 27, 2025 | 23.71% |
| Mar 28, 2025 | -29.39% |
| Dec 31, 2024 | -137.93% |
| Sep 27, 2024 | 26.27% |
| Jun 28, 2024 | -92.17% |
| Mar 29, 2024 | 44.15% |
| Dec 31, 2023 | -224.71% |
| Sep 29, 2023 | 282.32% |
| Jun 30, 2023 | 9.28% |
| Mar 31, 2023 | 27.67% |
| Dec 31, 2022 | -47.68% |
| Sep 30, 2022 | -47.40% |
| Jul 1, 2022 | -34.62% |
| Apr 1, 2022 | -27.29% |
| Dec 31, 2021 | 27.87% |
| Oct 1, 2021 | -261.23% |